WayneVMooreMD

Pediatric Endocrinology • Kansas City, MO

Pediatric Diabetes Endocrinology, Pediatric Growth Disorder Endocrinology, Pediatric Obesity

Professor, Pediatrics, University of Missouri, Kansas City School of Medicine

Join to view full profile

Dr. Moore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moore's full profile

Already have an account?

Office
3101 Broadway
Kansas City, MO 64111

Education & Training

University of MinnesotaResidency, Pediatrics, 1970 - 1972
University of Minnesota Medical SchoolClass of 1970
National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology

Certifications & Licensure

KS State Medical License 1974 - 2025
MO State Medical License 1995 - 2025
MN State Medical License 1971 - 1978
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein Start of enrollment: 2005 Jul 01
Completed
Molecular Quantification of Insulin mRNA Start of enrollment: 2006 Feb 01
Completed
Type 1 Diabetes Extension Study Start of enrollment: 2016 Aug 18
Recruiting

Publications & Presentations

PubMed

Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
Laura M Jacobsen, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore
Diabetes Care. 2024-06-01
29 citations
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J Weiner, Sai Kanaparthi
JCI Insight. 2021-11-08
4 citations
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts.
Michael G. Voss, David Cuthbertson, Mario M. Cleves, Ping Xu, Carmella Evans-Molina
Diabetes Care. 2021-08-06

Lectures

89th Annual Fall Clinical Conference
Kansas City Southwest Clinical Society, Overland Park, Kansas - 11/3/2011

Press Mentions

Children's Mercy Clinics Team up to Fight DiabetesJanuary 18th, 2016

Grant Support

Combined Islet And Renal TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1989

Professional Memberships